Delivery Order SPE2DB22D9316-SPE2DB24FYN40
Award Date
2/13/24
Potential Completion Date
2/14/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The $25,868.10 order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, to be delivered by January 8, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a variety of brand name and generic prescription and over-the-counter drug supplies to the Department of Defense. This delivery order is part of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,311.35 contract is for the supply of a pharmaceuticals item, XTANDI 40 MG CAPSULE 120S, with a performance period through September 9, 2024. DMS Pharmaceutical Group is an established federal contractor that holds a large $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price Delivery Order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued at up to $4,999,999 through 2025, to provide a broad range of pharmaceutical items to military health facilities worldwide. DMS...
The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 120 capsules of the pharmaceutical product XTANDI 40 MG. The $8,622.72 order has a completion date of January 17, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts to supply pharmaceuticals and medical products to support military treatment facilities worldwide. This delivery order is issued...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 120 capsules of the pharmaceutical product XTANDI 40 MG, with a potential value of $4,311.35 and a completion date of December 29, 2023. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides brand and generic prescription and over-the-counter drug supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. The Firm Fixed Price contract is valued at $4,311.35 and has an ultimate completion date of May 23, 2024. DMS Pharmaceutical Group Inc. is a prime vendor for the DLA's Medical Supply Chain division, providing a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $4,321.50 order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, with a completion date of May 11, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB medical supply contract, awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,311.35 order is for 4565153076 - XTANDI 40 MG CAPSULE 120S. DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to the Department of Defense and Department of Veterans Affairs through various prime and subcontracts. The company holds a...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XTANDI 40 MG CAPSULE 120S. This order is valued at $51,736.20 and has a completion date of January 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical products to the Department of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,311.35 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...